Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intrathecal baclofen for generalized dystonia.

A L Albright1, M J Barry, D H Shafton

  • 1Department of Neurosurgery, Children's Hospital of Pittsburgh, PA 15213, USA. albrigl@chplink.chp.edu

Developmental Medicine and Child Neurology
|October 23, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Dark Matter Search Results from the LUX-ZEPLIN (LZ) Experiment.

Physical review letters·2023
Same author

Sociodemographic characteristics associated with a higher wish to complain about health care.

Public health·2022
Same author

Radial scars and complex sclerosing lesions on core needle biopsy of the breast: upgrade rates and long-term outcomes.

Breast cancer research and treatment·2020
Same author

Inducible defences in Daphnia: responses to two closely related predator species.

Oecologia·2017
Same author

Prevention of type 2 diabetes: the strategic approach for implementation.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2011
Same author

Tattoos and Identity.

Canadian Medical Association journal·2010

Intrathecal baclofen (ITB) effectively treats severe generalized dystonia when oral medications fail. This therapy significantly reduces dystonia symptoms and improves quality of life in most patients.

Area of Science:

  • Neurology
  • Neurosurgery
  • Physical Medicine and Rehabilitation

Background:

  • Generalized dystonia is a debilitating neurological disorder.
  • Severe cases often become refractory to conventional oral pharmacotherapy.
  • Intrathecal baclofen therapy (ITB) offers an alternative for managing refractory symptoms.

Purpose of the Study:

  • To evaluate the efficacy and safety of ITB in patients with severe generalized dystonia.
  • To assess long-term outcomes and patient-reported improvements.
  • To identify factors influencing treatment response.

Main Methods:

  • Retrospective analysis of 86 patients (3-42 years) with generalized dystonia treated with ITB.
  • Screening via continuous infusion or bolus injection followed by pump implantation in responders.

Related Experiment Videos

  • Dystonia severity scoring and patient questionnaires assessed at baseline and follow-up intervals up to 24 months.

    • Main Results:

    • 91-93% of patients responded to initial ITB screening.
    • Significant reductions in dystonia scores observed at 3, 6, 12, and 24 months (p<0.005).
    • Catheter placement at T4 or higher correlated with better outcomes (p=0.005).
    • 92% maintained response at a median 29-month follow-up.
    • 86% reported improved quality of life; 33% improved speech.
    • Adverse events occurred in 26%, surgical complications in 38%.

    Conclusions:

    • ITB is a highly effective treatment for severe generalized dystonia refractory to oral medications.
    • ITB offers significant long-term symptom control and functional improvement.
    • While surgical complications exist, ITB is likely the treatment of choice for refractory cases.